Lise Lotte N Husemoen
Overview
Explore the profile of Lise Lotte N Husemoen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
945
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thorius I, Petersen J, Husemoen L, Alibegovic A, Gall M, Damm P, et al.
Obstet Gynecol
. 2024 Sep;
144(5):725-732.
PMID: 39236320
Objective: To investigate the association between maternal glycemic control and the risk of congenital malformations in offspring of women with type 1 diabetes and to examine whether there is a...
2.
Murata T, Husemoen L, Nemoto S, Matsuhisa M
Diabetol Int
. 2024 Jan;
15(1):76-85.
PMID: 38264229
Introduction: Insulin degludec (degludec) is a basal insulin with a long duration of action. This post-marketing surveillance study monitored safety and glycemic control during use of degludec for 3 years...
3.
Thorius I, Husemoen L, Nordsborg R, Alibegovic A, Gall M, Petersen J, et al.
Diabetes Care
. 2023 Dec;
47(3):384-392.
PMID: 38128075
Objective: To compare the risk of fetal overgrowth and preterm delivery in pregnant women with type 1 diabetes (T1D) treated with insulin pumps versus multiple daily injections (MDI) and examine...
4.
Verma S, Alamuddin N, Alawadi F, Alkandari H, Almahmeed W, Assaad-Khalil S, et al.
Circulation
. 2023 Mar;
147(16):1251-1255.
PMID: 36877670
No abstract available.
5.
Thorius I, Husemoen L, Nordsborg R, Alibegovic A, Gall M, Petersen J, et al.
Diabetologia
. 2023 Jan;
66(5):826-836.
PMID: 36640191
Aims/hypothesis: Continuous subcutaneous insulin infusion by insulin pump is often superior in improving glycaemic control compared with conventional multiple daily insulin injection (MDI). However, whether pump treatment leads to improved...
6.
Lane W, Faurby M, Husemoen L, Markovich D, Rathor N, De Block C
Diabetes Ther
. 2021 Oct;
12(12):3067-3077.
PMID: 34637112
Introduction: This study investigated glycaemic control in individuals with type 1 (T1D) or type 2 diabetes (T2D) 6 months after initiating fast-acting insulin aspart (faster aspart) in a real-world setting....
7.
Khunti K, Hertz C, Husemoen L, Mocevic E, Nordsborg R, Piltoft J, et al.
Diabet Med
. 2021 Sep;
39(3):e14697.
PMID: 34558105
Aims: To characterise the cardiovascular risk of people with type 2 diabetes without established cardiovascular disease but with risk factors, relative to those with established cardiovascular disease, to provide information...
8.
Mathiesen E, Ali N, Alibegovic A, Anastasiou E, Cypryk K, de Valk H, et al.
Diabetes Care
. 2021 Jul;
44(9):2069-2077.
PMID: 34330786
Objective: To compare the risk of severe adverse pregnancy complications in women with preexisting diabetes. Research Design And Methods: Multinational, prospective cohort study to assess the prevalence of newborns free...
9.
Mathiesen E, Ali N, Anastasiou E, Cypryk K, de Valk H, Dores J, et al.
J Matern Fetal Neonatal Med
. 2021 Jun;
35(25):7992-8000.
PMID: 34182866
Aims: To examine clinical parameters, glycemic control, folic acid supplementation, and the presence of other chronic diseases during early pregnancy in the EVOLVE study population (women with pre-existing diabetes treated...
10.
Murthy S, Aneja P, Asirvatham A, Husemoen L, Rhee N, Kesavadev J
Pharmacoecon Open
. 2021 Jan;
5(2):261-273.
PMID: 33410093
Objective: Our objective was to investigate willingness to pay (WTP) for biphasic insulin aspart 30/70 (BIAsp 30) in patients with type 2 diabetes mellitus (T2DM) in India. Methods: A multicenter,...